US2009270503A1PendingUtilityA1

Nutritional supplements

78
Assignee: DRUGTECH CORPPriority: Jun 1, 1999Filed: Oct 29, 2008Published: Oct 29, 2009
Est. expiryJun 1, 2019(expired)· nominal 20-yr term from priority
A23V 2002/00A23L 33/12A61P 3/02A23L 33/10
78
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize embryonic, fetal and child neurological development and provides improved nutritional support for women prior to and during lactation. Further the methods and compositions improve gestational length and birth weight. The nutritional methods and compositions are also intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.

Claims

exact text as granted — not AI-modified
1 . A composition for supplementing the diet, the composition comprising:
 a. a first fatty acid; and   b. DHA present in a quantity such that the total amount of said first fatty acid and said DHA is from about 10 mg to about 1000 mg.   
     
     
         2 . A composition for administration to a pregnant or lactating woman, the composition comprising:
 a. a first fatty acid; and   b. DHA present in a quantity such that the total amount of said first fatty acid and said DHA is from about 10 mg to about 1000 mg.   
     
     
         3 . A method for administering essential fatty acids, which comprises:
 a. administering a first fatty acid; and   b. administering DHA present in a quantity such that the total amount of said first fatty acid and said DHA is from about 10 mg to about 1000 mg.   
     
     
         4 . A method for administering essential fatty acids to pregnant or lactating women, which comprises:
 a. administering a first fatty acid; and   b. administering DHA present in a quantity such that the total amount of said first fatty acid and said DHA is from about 10 mg to about 1000 mg.   
     
     
         5 . The composition of  claim 1 , wherein the ratio of the amount of said first fatty acid to said DHA is from about 1:0.001 to about 1:50. 
     
     
         6 . The composition of  claim 2 , wherein the ratio of the amount of said first fatty acid to said DHA is from about 1:0.001 to about 1:50. 
     
     
         7 . The method of  claim 3 , wherein the ratio of the amount of said first fatty acid to said DHA is from about 1:0.001 to about 1:50. 
     
     
         8 . The method of  claim 4 , wherein the ratio of the amount of said first fatty acid to said DHA is from about 1:0.001 to about 1:50.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.